Drug Shortage Report for DESVENLAFAXINE
| Report ID | 223265 |
| Drug Identification Number | 02535114 |
| Brand name | DESVENLAFAXINE |
| Common or Proper name | DESVENLAFAXINE |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DESVENLAFAXINE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-25 |
| Estimated end date | 2024-04-20 |
| Actual end date | 2024-04-18 |
| Shortage status | Resolved |
| Updated date | 2024-04-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-04-19 | English | Compare |
| v5 | 2024-04-18 | French | Compare |
| v4 | 2024-04-18 | English | Compare |
| v3 | 2024-03-26 | English | Compare |
| v2 | 2024-03-25 | French | Compare |
| v1 | 2024-03-25 | English | Compare |
Showing 1 to 6 of 6